Disclosure.net

When Antisoma did its first webcast late last year, the London-based bio-pharmaceutical concern was hoping to attract new investors from outside its domestic market. Valerie Tate, Antisoma's investor relations officer, says, 'We decided to bite the bullet because this seemed like a tremendous opportunity to raise our profile not just in the UK but outside the UK as well.'For her first webcast, Tate chose an occasion that she felt would appeal to German investors: Antisoma was licensing a product